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Background: Phage-encoded serine integrases, such as φC31 integrase, are widely used for genome engineering. Fifteen
such integrases have been described but their utility for genome engineering has not been compared in uniform assays.
Results:We have compared fifteen serine integrases for their utility for DNA manipulations in mammalian cells after first
demonstrating that all were functional in E. coli. Chromosomal recombination reporters were used to show that seven
integrases were active on chromosomally integrated DNA in human fibroblasts and mouse embryonic stem cells. Five of
the remaining eight enzymes were active on extra-chromosomal substrates thereby demonstrating that the ability to
mediate extra-chromosomal recombination is no guide to ability to mediate site-specific recombination on integrated DNA.
All the integrases that were active on integrated DNA also promoted DNA integration reactions that were not mediated
through conservative site-specific recombination or damaged the recombination sites but the extent of these aberrant
reactions varied over at least an order of magnitude. Bxb1 integrase yielded approximately two-fold more recombinants and
displayed about two fold less damage to the recombination sites than the next best recombinase; φC31 integrase.
Conclusions: We conclude that the Bxb1 and φC31 integrases are the reagents of choice for genome engineering in
vertebrate cells and that DNA damage repair is a major limitation upon the utility of this class of site-specific recombinase.
Keywords: Serine recombinases, Genome manipulation, DNA damageBackground
Serine integrases are phage-encoded site-specific recombinases
that promote conservative recombination reactions be-
tween short (40-60 bp) DNA substrates located on the
phage (phage attachment site, attP) and bacterial (bacter-
ial attachment site, attB) chromosomes [1]. The product
of attP × attB recombination is an integrated prophage
flanked by two new recombination sites, attL and attR,
each containing half sites derived from attP and attB. In
the absence of accessory factors the integrases mediate
unidirectional recombination between attP and attB
with greater than 80% efficiency. In the presence of a
phage-encoded accessory protein, the recombination
directionality factor (RDF) the attP × attB recombin-
ation is inhibited and the attL × attR recombination is* Correspondence: william.brown@nottingham.ac.uk
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reproduction in any medium, provided the orstimulated [2,3]. In this way integration (attP × attB)
and excision (attL × attR) of the phage genome are
under strict controls and in tune with the phage life
cycles. The unidirectional activity, short substrate sites
and functional autonomy of these recombinases has
made them a useful complement to the widely used re-
versible recombinases of the tyrosine recombinase
family such as Cre and Flp for genome engineering
reviewed in [1]. In particular the unidirectional activity
has made them valuable for the promotion of DNA in-
tegration by recombinase-mediated cassette exchange
reactions and for the development of iterative recom-
bination approaches [4-7]. To date five serine integrases
derived from phages φC31 [8], φBT1 [9], Bxb1 [10,11] and
R4 [11,12] have been shown to be capable of promoting
site-specific integration of DNA into mammalian genomes
while TP901-1 [13], A118, FC1 and φRV [14] have been
shown to promote site-specific recombination in an
extra-chromosomal environment in mammalian cells.
With one exception these studies have, however, beenThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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different cell lines, cells of different species and using
different protocols. The exceptional study was that of
Yamaguchi and colleagues [11] who compared the ac-
tivities of the φC31, Bxb1, TP901-1 and R4 integrases
in mediating site-specific recombination into a hu-
man artificial chromosome (HAC) isolated in hamster
cells. This study exploited a promoter trap strategy
and thus relied upon selection to assay recombination
products. Importantly, however, the products were not an-
alyzed at the level of DNA sequence. It was therefore nei-
ther possible to determine the total level of recombination
promoted by these different enzymes nor to determine the
fraction of recombination events that had proceeded by
reciprocal and conservative site-specific recombination.
The discovery that site-specific recombination mediated
by the φC31 integrase is sometimes accompanied by DNA
damage in vertebrate cells identified [15] posed the ques-
tion as how far integrase associated DNA damage limits
the use of the serine integrases as genome engineering re-
agents. Damage of the type seen with the φC31 integrase,
has not been detected with the tyrosine recombinases, is
likely to be a consequence of the DNA cleavage and strand
exchange mechanism of the serine recombinases (reviewed
in [16]). The recombination pathway begins with binding
of integrase to the attachment sites, which are then brought
together by protein:protein interactions to form a synaptic
tetramer. The reaction then proceeds by the formation of
concerted double strand breaks in both of the DNA
substrates prior to subunit rotation and recombination.
It seems likely that the damage that accompanies the
activity of these recombinases in vertebrate cells arises
as a consequence of these double strand breaks being
recognized by the mammalian cell double strand break
repair pathways. It should be noted that to date no
damage has ever been observed to accompany the ac-
tion of the serine integrases in bacteria and it may
therefore be the eukaryotic chromatin environment or
the nature of the mammalian repair pathways that
leads to the damage seen in mammalian cells. The fre-
quency and extent of the damage would seem likely to
reflect the time spent by the integrases in the cova-
lently linked, cleaved DNA complex as this is most
likely to be the target for the repair pathways.
In total there are fifteen phage-encoded serine integrases
for which both of their attachment sites are known. Nine
of these fifteen integrases have been characterised in reac-
tions in mammalian cells, E. coli or in vitro (φC31 [17],
Bxb1 [18], φBT1 [19], φC1 [14,20], MR11 [21], TP901-1
[22], R4 [12], A118 [14], and φRV [14], [23]) while six
(TG1, φ370.1 [24], Wβ [25], BL3, SPBc and K38) have not
yet been shown to be active outside their native hosts. In
total there are ten integrases whose utility as tools for in-
tegrating DNA into mammalian genomes has not beeninvestigated. We have therefore set out to rank the ac-
tivities of all fifteen of these serine integrases for which
the sites are known by the criteria of both accuracy
and efficiency in two different mammalian cell lines;
human HT1080 cells and mouse ES cells. These stud-
ies have provided us with a clear rank order for the
utility of this important class of enzymes as tools for
vertebrate genome engineering with Bxb1 integrase
mediating the most efficient and accurate site-specific
recombination in this heterologous environment. The
φC31 integrase comes a close second. For the remaining
integrases, we demonstrate that DNA damage is an im-
portant factor in limiting the utility of members of this
class of enzymes for promoting integration reactions in
mammalian cells.
Results and discussion
Fifteen unidirectional ‘phage integrases are active in E. coli
Fifteen unidirectional phage integrases have been de-
scribed for which the attachment sites are known. We
first set out to confirm that each integrase and their cog-
nate attachment sites were active by expression of each
integrase gene in E. coli in the presence of a reporter
plasmid. Fifteen reporter plasmids (conferring chloram-
phenicol resistance) were constructed in which the
lacZα gene was flanked by attB and attP sites for each
of the respective integrases (Figure 1A). These plasmids
conferred exclusively blue colony when transformed into
an E. coli strain containing the lacZΔM15 mutation and
plated on selective agar in the presence of X-gal and IPTG
(Figure 1B, top row). We next introduced genes encoding
each one of the integrases tagged at the N-terminal end
by a StrepII tag and at the C-terminal end by a SV40 large
T antigen nuclear localization signal into the E. coli ex-
pression plasmid pET21a (conferring ampicillin resist-
ance). Initially we introduced the integrase expression
plasmids into DH5α E. coli K12 strains containing a cog-
nate reporter plasmid and scored the transformants as
white or light blue, indicative of recombination, or blue,
indicative of no recombination. Active integrases were
from phages φC31, Bxb1, TG1, TP901-1, A118, SPBc, Wβ,
φBT1 and φ370.1 in this assay (Figure 1B, middle row).
The transformants containing integrase genes that only
gave rise to blue or light blue colonies were picked and
restreaked to single colonies and white colonies were ob-
served from strains expressing BL3, FC1 and K38
integrases whereas no white segregants were observed
from strains containing MR11, φRV and R4 int genes
(Figure 1B, bottom row).
As the expression of the integrases might be limiting in
bacteria containing the MR11, φRV and R4 integrase
genes, we repeated the recombination assay in E. coli
BL21(DE3), a strain that should over-express the integrase
genes on induction with IPTG. Competent BL21(DE3)
Table 1 In vivo recombination activity after
overexpression of integrases in E. coli BL21(DE3)
Integrase μg tagged protein/ml1 % recombination2
Bxb1 ND 100
Wβ ND 100
BL3 ND 100
φR4 ND 100
A118 0.6 100
TG1 2.7 100
MR11 2.9 50
φ370 4.1 100
SPBc 9.0 100
TP901-1 32.3 100
φRV 55.9 75
FC1 74.7 100
K38 319.6 100
φBT1 350.4 100
φC31 758.2 100
1The amount of StrepII tagged integrase detected in a Western blot from 1 ml
of culture.
2The % of plasmid extracted from the cultures that had
undergone recombination.
BL3C31 K38TG1 TP901 WβA118Bxb1
-int
+int
+int
(restreak) ND ND ND ND ND
BT1 MR11R4 RVSPBc FC1370.1B
A
Figure 1 Assaying integrase activity in E.coli. A. The reporter plasmid used to assay activity of the integrases in E. coli. This plasmid, derived
from pACYC184, contains lacZα gene encoding the LacZα peptide flanked by integrase attachment sites. The intact reporter plasmid confers
β-galactisidase activity on a strain containing the ΔlacZM15 allele and therefore the colonies appear blue on agar containing presence of X-
Gal and IPTG. Active integrase promotes site-specific recombination between the attP and attB sites resulting in deletion of the lacZα gene
and the colonies appear white. B. The appearance of E.coli containing the reporter plasmid with or without an integrase expression plasmid
in the presence of X-Gal and IPTG.
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pared and the integrase containing expression plas-
mids introduced by transformation with selection for
ampicillin and chloramphenicol resistance. Expression
of integrase was induced by addition of IPTG to loga-
rithmically growing cells and cultures were further incu-
bated overnight at 20°C. Plasmid DNA was extracted from
1 ml of each culture and used to transform plasmid free
DH5α scoring for white and blue colonies. All of the plas-
mids extracted from the E. coli BL21(DE3) cells expressing
the integrases gave exclusively white colonies with the ex-
ception of strains that had contained MR11 or φRV
integrases, which yielded 50% and 25% unrecombined
plasmid, respectively (Table 1). The control BL21(DE3)
strains that contained the reporter plasmids and the
empty expression plasmid (pET21a) remained stable
with no loss of the lacZα gene. Accurate site-specific
recombination for all of the integrases was confirmed
by PCR and sequencing of the attL sites recovered from
plasmids present in the white colonies. Cells from the
same cultures were used to assay the level of expression of
the StrepII-tagged integrases by western blots (Table 1). A
StrepII-tagged integrase of the expected molecular weight
was detected from all the BL21 (DE3) strains expressing
an integrase except those containing the Wβ, Bxb1, BL3
or R4 integrase genes. The amount of protein present was
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from the western blotting with those from a series of stan-
dards (Table 1). While there was no simple relationship
between the amounts of protein detected in the cultures
and the level of recombination, this experiment demon-
strated that all the integrases and their attachment sites
were active in E. coli.
Assaying the unidirectional phage integrases in
vertebrate cells
The activities of the integrases were then measured in
vertebrate cells. In order to do this we constructed three
reporter plasmids that could be used to assay the ability
of all of the different integrases to mediate either dele-
tion or integration in mammalian cells. Each of the re-
porter plasmids included arrays containing attP or attB
sites for all 15 integrases arranged head-to-tail. For the
deletion assay we used a plasmid, called ‘attP array CCAG
HyTK attB array’ (Figure 2A), in which a counter select-
able marker gene, a fusion between a gene conferringattP array CCAG HyTK attB/P 
attP array HyTK fusionCCAG promoter
C
Ampicil
resistan
CCAG prom
attB array
attB array
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Neo
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Figure 2 Assay system for integrases in mammalian cells. The reporter
integration promoted by serine integrases in vertebrate cells. In the deletio
counter selectable gene CCAG HyTK was placed between an array of attB s
recombinase-mediated cassette exchange constructs, the docking construc
by two arrays of attP sites and the reporter construct, termed attB array CC
resistance to G418 flanked by arrays of attB sites. The integrase expression
modified at the 5′ and 3′ ends to encode a StrepII tag and a nuclear localizati
and upstream of an internal ribosome entry site and a dominant selectable mresistance to hygromycin and a herpes simplex virus thy-
midine kinase gene that confers sensitivity to the nucleo-
side analogue gancyclovir, HyTK, was placed between
arrays of attB and attP sites in a head-to-tail orientation
(Figures 2B and 2C). If integrase mediated recombination
occurs between its cognate attP and attB sites flanking
the HyTK gene, the cells become resistant to gancyclovir.
The assay for integration activity was based upon the use
of two plasmids. The first of these, called ‘attP array
CCAG HyTK attP array’, contained the docking attP sites,
flanking the counter selectable marker (Figure 2A) and
the second, called ‘attB array CCAG neo attB array’,
contained the incoming attB sites flanking a gene encod-
ing resistance to the antibiotic G418 (Figure 2D). Cassette
exchange between the incoming attB sites and the docking
attP sites is expected to yield chromosomes containing attR
and attL flanking the integrated neo gene and the cells dis-
play both gangcylovir and G418 resistance.
In both assays the integrases were expressed using
plasmids (Figure 2E) in which each integrase gene hadarray
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plasmid design (A) used to assay either site-specific deletion or
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ites (B) and an array of attP sites (C). In the integration or
t, attP array CCAG HyTK attP array, had the CCAG HyTK gene flanked
AG neo attB array (D) contained the CCAG Neo gene conferring
constructs are shown schematically in (E) each containing an int gene
on signal, respectively, and placed down-stream of a CCAG promoter
arker conferring either zeocin or xanthine resistance (ecogpt).
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ends encoding the StrepII tag and the nuclear localization
signal. An internal ribosome entry site (IRES) followed by
an antibiotic resistance gene was placed downstream of
each integrase gene.
The use of arrays of attachment sites in the reporter
plasmids had three merits: Firstly it enabled a strategy
that ensured that comparisons between the different
integrases were not compromised by position effects
arising as a result of the target sites for the different
integrases being integrated at different positions in the0.0 
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Figure 3 Comparing the activity of ϕC31 integrase on isolated attach
A-E. Assays ϕC31 integrase activity on attachment sites in different configu
were incubated in the absence or in the presence of 0 nM (lane 1), 100 nM
integrase. Recombination reactions were digested with either HindIII or Bam
F. The data shown in A-E were analyzed densitometrically and the fraction
materials and methods. This comparative analysis was carried out in two invertebrate genome. Secondly it allowed us to determine
whether there was any cross-reactivity between the dif-
ferent integrases and their attachment sites. Finally this
approach proved to be efficient, requiring only a small
number of cell lines to be used for all of the necessary
assays. However as a precaution, we wanted to exclude
the possibility that placing the attachment sites within
an array altered their activity and so we compared the
in vitro activity of one of the integrases, φC31 integrase,
using substrates in which the attachment sites were ei-
ther isolated or present in the arrays (Figure 3A-E).00 600 700 800 
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rations. The indicated plasmids containing either attB or attP sites
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HI and the products size fractionated by agarose gel electrophoresis.
of the substrate converted into product calculated as described in the
dependent experiments.
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ciencies of the attachment sites were similar whether
they were isolated or present in the arrays.
Identification of eight unidirectional phage integrases
promoting site-specific deletion in mammalian cells
Firstly we wanted to determine which of the fifteen
integrases were active on substrates integrated into verte-
brate genomes. The most sensitive way in which to detect
activity is to assay recombination between attB and an
attP sites in cis because the proximity of the sites favours
the kinetics of synapsis, the process by which integrase
bring the substrates together in a tetramer prior to DNA
cleavage. We therefore transfected the construct designed
to assay deletion, attP array CCAG HyTK attB array, into
human HT1080 cells by electroporation and selected for
stable transfectants using hygromycin. We screened 96
stably transfected clones for the integrity of the integrated
DNA using PCR, checked for single copy integrants by re-
striction enzyme analysis and filter hybridization and then
confirmed the integrity of the attP and attB arrays by se-
quencing. In this way we recovered four independent, sta-
bly transfected clones from two independent transfections,
each containing a single copy of the integrated deletion re-
porter construct, attP array CCAG HyTK attB array.
In order to compare the activities of the different
integrases we first transiently transfected 105 HT1080
cells containing the attP array CCAG HyTK attB array
reporter with expression plasmids for each of the integrases
using Lipofectamine and assayed for recombination activity
by selecting for resistance to gancyclovir, a drug which is
selectively toxic for cells expressing the HyTK fusion. None
of the integrases gave a significant increase in the number
of gancyclovir-resistant cells as compared to the empty ex-
pression vector (Adiitional file 1: Table S3) and so we
assayed pools of the resistant cells for the presence of the
recombinant attR site using PCR. Recombination activity
was detected in populations of cells transfected with the
R4, φC31, φBT1, Bxb1, SPBC and Wβ integrase expression
constructs (not shown). However the low level of activity
overall made it impossible to conclude anything about the
integrases that did not yield attR in the PCR reactions as
the integrases may be active but causing damage that re-
moved the attR primer binding sites, may simply be
slow in promoting site-specific recombination or com-
pletely inactive. Moreover the variability of the relative
numbers of gancyclovir resistant clones generated in dif-
ferent experiments made an accurate comparison between
the active integrases impractical.
We therefore used electroporation to transfect linear-
ized integrase expression constructs into each of the two
independent cell lines containing the attP array CCAG
HyTK attB array reporter used in the transient expres-
sion experiments and selected for clones containing stablyintegrated, integrase expression constructs (Additional file 1:
Table S4). The yield of clones generated by the integrase ex-
pression constructs was at least an order of magnitude lower
than those recovered following transfection with the empty
expression vector suggesting that all of the integrases were
toxic to various degrees. The TG1 and φ370.1 integrases
appeared particularly toxic by this criterion because these
consistently gave us no stably transfected clones. We divided
the clones that had been stably transfected with each of the
integrases into two groups of approximately equal sizes. We
used the first of these groups to estimate the ability of the
integrases to promote site-specific recombination of the attP
array CCAG HyTK attB array reporter construct within the
first two weeks of exposure to integrase. In order to do this
we applied gancyclovir selection to these clones and then
assayed individual gancyclovir resistant clones for one of the
recombinant products, attR, by PCR. The six integrases that
had shown clearly detectable activity in the transient trans-
fection experiment (R4, φC31, φBT1, Bxb1, SPBc and Wβ)
showed activity after stable expression of the integrase
(Figure 4A). The remaining integrases showed no evi-
dence for site-specific recombinase activity following
gancyclovir selection. We wanted to determine how
accurately the six active integrases were mediating
site-specific recombination. We therefore sequenced at
least 7 PCR products containing recombinant attR
sites derived from each of the six active integrases and
showed that, with the notable exception of the R4
integrase, all exclusively yielded products that were consist-
ent with conservative site-specific recombination (Table 2).
In the case of the R4 integrase only 2/9 PCR products
contained intact attR sites, demonstrating that this enzyme
seems particularly damage prone, at least in human cells.
We wanted to know whether the complete failure to
detect deletion activity after two weeks of growth in the
presence TP901-1, FC1, φ370.1, K38, φRV, A118, BL3
and MR11 integrases was because these recombinases
were slow or because they were damaging the target
sites. We therefore applied hygromycin selection to the
second group of clones that had been stably transfected
with the integrase expression construct but not exposed to
gancyclovir, then relaxed hygromycin selection and
analysed the clones for any detectable recombination after
a further two weeks by PCR. The results were clear;
TP901-1 integrase showed detectable recombination after
further culture indicating that it was indeed slow but the
remaining integrases showed no evidence of recombination
(Additional file 1: Table S4). As before we determined the
sequence of the PCR products containing the predicted
attR site generated by the TP901-1 integrase; 4 were intact
attR sites and 1 was damaged thus showing that TP901-1
integrase is like the R4 integrase and prone to site damage.
We wanted to know whether the remaining 8 integrases
that had failed to show productive recombination were
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Figure 4 Comparing the activity of fifteen serine recombinases in human HT1080 cells and in mouse ES cells. A. HT1080 cells containing
a single integrated attP array CCAG HyTK attB array reporter construct were stably transfected with an integrase expression plasmid selecting for
antibiotic resistance. The transfected clones were then subjected to gancyclovir selection to identify those that had lost the CCAG HyTK marker
gene and then screened for recombinant attR sites to identify those that had undergone integrase-mediated site-specific deletion of CCAG HyTK.
The two bars shown for each integrase reflect the results of two independent experiments. (Additional file 1: Table S4). None of the other eight
integrases yielded recombinant gancyclovir resistant clones and they are not shown in this part of the figure. B; ES cells containing a attP array
CCAG HyTK attB array reporter integrated at the ROSA26 locus were transiently co-transfected with an integrase expression plasmid and a
linearized PGKneo construct to normalize for differences in the efficiency of transfection. Gancyclovir resistant clones were screened for attR sites.
Two experiments were carried out and the bars reflect the means of the normalized activities (Additional file 1: Table S5). The analyses were
carried out twice on a single attP array CCAG HyTK attB array reporter cell line and thus the data is shown as the mean of the two experiments.
C; HT1080 cells that had been transfected with the empty expression vector (CCAG iresZeo) or with the indicated integrase expression vector
were transiently transfected with the attP array CCAG HyTK attB array reporter and scored for site-specific recombination by PCR. For ϕ370 and
TG1 integrases the integrase expression vector was co-transfected with the reporter construct, the remaining experiments were carried out with
HT1080 cell lines that had been stably transfected with the respective integrase expression construct.
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the attachment sites. We therefore sequenced their
substrate attachment sites (attP and attB) in the inte-
grated reporter plasmids in two of the hygromycin resist-
ant clones that had been transfected with the respectiveintegrase expression constructs. None showed evidence of
site damage.
Thus we concluded that the R4, φC31, φBT1, Bxb1,
SPBc, TP901-1 and Wβ integrases are active on sub-
strates integrated in to the genome of HT1080 cells
Table 2 Accuracy of integrase mediated site-specific recombination in human HT1080 and mouse ES cells
Integrase Sequence Integrations Deletions
BxB1 HT1080 ES
attB TCGGCCGGCTTGTCGACGACGGCGGTCTCCGTCGTCAGGATCATCCGGGC
attP GTCGTGGTTTGTCTGGTCAACCACCGCGGTCTCAGTGGTGTACGGTACAAACCCCGAC
attL TCGGCCGGCTTGTCGACGACGGCGGTCTCAGTGGTGTACGGTACAAACCCCGAC 3/3
attR GTCGTGGTTTGTCTGGTCAACCACCGCGGTCTCCGTCGTCAGGATCATCCGGGC 7/7 2/2
fC31
attB TGCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTACTCC
attP GTGCCCCAACTGGGGTAACCTTTGAGTTCTCTCAGTTGGGGG
attL TGCGGGTGCCAGGGCGTGCCCTTGAGTTCTCTCAGTTGGGGG 3/3
attR TTGCCCCAACTGGGGTAACCTTTGGGCTCCCCGGGCGCGTACTCC 7/7 3/3
R4
attB GCGCCCAAGTTGCCCATGACCATGCCGAAGCAGTGGTAGAAGGGCACCGGCAGACAC
attP AGGCATGTTCCCCAAAGCGATACCACTTGAAGCAGTGGTACTGCTTGTGGGTACACTCTGC
attL GCGCCCAAGTTGCCCATGACCATGCCGAAGCAGTGGTACTGCTTGTGGGTACACTCTGC 3/3
attR AGGCATGTTCCCCAAAGCGATACCACTTGAAGCAGTGGTAGAAGGGCACCGGCAGACAC 2/9 1/2
del clone 1 DattR AGGCATGTTCCCCAAAGCGATACCAC AAGCAGTGGTAGAAGGGCACCGGCAGACAC
del clone 2 DattR AGGCATGTTCCCCAAAGCGATACCACTT AAGCAGTGGTAGAAGGGCACCGGCAGACAC
del clone 3 DattR AGGCATGTTCCCCAAAGCGATACCACTTG GCAGTGGTAGAAGGGCACCGGCAGACAC
del clone 4 DattR AGGCATGTTCCCCAAAGCGATA GCAGTGGTAGAAGGGCACCGGCAGACAC
del clone 5 DattR AGGCATGTTCCCCAAAGCGATACCA GTGGTAGAAGGGCACCGGCAGACAC
del clone 6 DattR AGGCATGTTCCCCAAAGCGATACCA GAAGCAGTGGTAGAAGGGCACCGGCAGACAC
del clone 7 DattR AGGCATGTTCCCCAAAGCGATACCAC AAGCAGTGGTAGAAGGGCACCGGCAGACAC
ES del clone 1 DattR AGGCATGTTCCCCAAAGCGATACCA AGCAGTGGTAGAAGGGCACCGGCAGACAC 1/2
intn clone 1-3 DattR AGGCATGTTCCCCAAAGCGATA CAGTGGTAGAAGGGCACCGGCAGACAC 3/3
fBT1
attB GTCCTTGACCAGGTTTTTGACGAAAGTGATCCAGATGATCCAGCTCCACACCCCGAACGC
attP GGTGCTGGGTTGTTGTCTCTGGACAGTGATCCATGGGAAACTACTCAGCACCACCAATG
attL GTCCTTGACCAGGTTTTTGACGAAAGTGATCCATGGGAAACTACTCAGCACCACCAATG 3/3
attR GGTGCTGGGTTGTTGTCTCTGGACAGTGATCCAGATGATCCAGCTCCACACCCCGAACGC 7/7 2/2
intn clone 1DattR GGTGCTGGGTTGTTGTCTC GATCCAGATGATCCAGCTCCACACCCCGAACGC 1/3
Wβ
attB AAGGTAGCGTCAACGATAGGTGTAACTGTCGTGTTTGTAACGGTACTTCCAACAGCTGGCG
attP TAGTTTTAAAGTTGGTTATTAGTTACTGTGATATTTATCACGGTACCCAATAACCAATGAA
attR TAGTTTTAAAGTTGGTTATTAGTTACTGTGATATTTGTAACGGTACTTCCAACAGCTGGCG 7/7 2/2
SPBc
attB AGTGCAGCATGTCATTAATATCAGTACAGATAAAGCTGTATCTCCTGTGAACACAATGGGTG 7/7 2/4
attP AAAGTAGTAAGTATCTTAAAAAACAGATAAAGCTGTATATTAAGATACTTACTAC
attR AAAGTAGTAAGTATCTTAAAAAACAGATAAAGCTGTATCTCCTGTGAACACAATGGGTG
ES del clone 1 DattR AAAGTAGTAAGTATCTTAAAAAACA———AGCTGTATCTCCTGTGAACACAATGGGTG 1/4
ES del clone 2 DattR aaaatacagcgtttttcatgtacaactatactGCTGTATCTCCTGTGAACACAATGGGTG 1/4
TP901
attB TGATAATTGCCAACACAATTAACATCTCAATCAAGGTAAATGCTTTTTCGTTTT
attP AATTGCGAGTTTTTATTTCGTTTATTTCAATTAAGGTAACTAAAAAACTCCTTT
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Table 2 Accuracy of integrase mediated site-specific recombination in human HT1080 and mouse ES cells (Continued)
attR AATTGCGAGTTTTTATTTCGTTTATTTCAAGGTAAATGCTTTTTCGTTTT 4/5
del clone 1 DattR AATTGCGAGTTTTTATTTCGTTTATTTC GGTAAATGCTTTTTCGTTTT 1/5
The results show the sequences of the recombinant sites detected following integrase mediate site specific recombination in human HT1080 or mouse ES cells.
Underlined and in lowercase in the case of one sequence from a deletion event occurring in ES cells following expression of the SPBc integrase is the sequence of
a flanking ϕ370.1 attP site discussed in the text.
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slowly and that the FC1, φK38, RV, A118, BL3 and
MR11 integrases are not detectably active on integrated
substrates. We cannot make any statement about the
TG1 and φ370.1 integrases because we were unable to re-
cover clones expressing these integrases for experimental
analysis. We attempted to use western blotting to assay
for expression of the integrases using with an antibody to
the N-terminal StrepII tag but we were unable to detect
any signal with any of the integrases suggesting that they
are all expressed at low levels. Rank ordering of the dele-
tion activities of the integrases in this experiment indi-
cated the following Bxb1 = φC31 = φBT1 > R4 =Wβ >
SPBc > TP901-1. The utility of the R4 integrase would
seem to be limited by its liability to site damage. The pur-
pose of this part of our project was to identify those en-
zymes that were active in vertebrate cells and we did not
investigate the background of GANCr attR- clones. Al-
though such clones were seen in the cells transfected with
the empty vector and may arise from background silen-
cing of the attP CCAG HyTK attB indicator gene or from
loss of the chromosome carrying this gene, they occur at a
higher level in the clones that had been transfected
with integrases (Additional file 1: Table S4). We cannot
exclude the possibility that they arise as a result of
recombinase-mediated target site damage, although the
accurate recombination activities seen with five of the
seven active integrases would suggest that this is unlikely.
The source of these background clones is therefore
unclear.
It is also clear that not all of the clones that were suc-
cessfully transfected with a construct expressing an ac-
tive integrase yielded recombinant products. Thus even
with the Bxb1 and φC31 integrases about 30% of the
clones that were resistant to the antibiotic used to select
for the presence of the expression construct failed to
yield clones that were resistant to gancyclovir and contained
an attR site. One hypothesis was that these clones failed to
express sufficient integrase to bind and synapse the sub-
strates, processes that are dependent on the affinity of
integrase for its attP and attB sites and the expression level
of integrase. We tried to test this idea by using the StrepII
epitope with which we had tagged all of the integrases but,
as before, were unable to do so for all of the integrases be-
cause the StrepII epitope tag was insufficiently sensitive and
no signal was obtained in the western blots. However we
had specific polyclonal antibodies for the φC31 and φBT1integrases that we expected would be more sensitive and in-
deed they allowed us to measure the presence of the re-
spective integrases by western blotting,. The results of this
analysis was consistent with the notion that at least for some
integrases the failure of site-specific recombination
was associated with inadequate or low levels of expres-
sion (Additional file 1: Figure S2). The success of the
western blotting using the polyclonal antibodies also
demonstrates that the previous failure to detect integrase
expression in the human cells using the StrepII tag and
antibody was due to the relatively low sensitivity of this
system.
The results obtained with the human HT1080 cells posed
the question of whether they were generally true for verte-
brate cells. Genome engineering of mouse embryonic stem
cells (ES cells) is widely practiced and so we used a deletion
strategy to assay the activities of the integrases in mouse ES
cells. We used sequence targeting to introduce the attP
array CCAG HyTK attB array deletion reporter cassette
into the ROSA26 locus (Additional file 1: Figure S1) and
then assayed for deletion by gancyclovir resistance fol-
lowing transient transfection with the set of integrase
expression constructs described above. In order to avoid
problems with toxicity that would compromise the prac-
tical significance of any results we chose to use transient
assays and an internal control to carry out the experiment.
In this ES cell system there appeared to be a clearer differ-
ence between the numbers of gancyclovir-resistant clones
seen with the empty vector and those with expressing
integrase than was observed in the HT1080 cells. The dif-
ference was not absolute however and identification of ac-
tive integrases also required PCR analysis for the presence
of a recombinant attR site. The results (Additional file 1:
Table S5 and Figure 4B) were similar but not identical to
those seen in the HT1080 cells; R4, φC31, φBT1, Bxb1,
SPBc, Wβ and TG1 integrases showed detectable activity
but the TP901-1 integrase did not. The activity seen with
the TG1 integrase was, however, weaker than seen with
the others with only one out of eight clones containing a
detectable attR site. Rank ordering of the deletion activities
of the integrases in this experiment indicated the following
Wβ > Bxb1 > φC31 > SPBc > R4 > φBT1. We analyzed the
accuracy of the site-specific recombination mediating the
deletion reaction in two gancyclovir-resistant clones
generated by the Bxb1, R4, Wβ and SPBc integrases.
These results demonstrated that the Bxb 1, φBT1 and
Wβ integrases all mediated site-specific recombination
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deletion in one of the two recombination products analyzed
and that both of the SPBc products were deleted. In the case
of the SPBc integrase the region deleted 171 bp in the attP
array extending as far as the φ370.1 attP site raising the pos-
sibility of a lack of specificity in attP site recognition by the
integrase. This however seems unlikely because the break-
point in the φ370.1 attP site is not at the proposed recom-
bination junction but 6 bp 3′ of the point of symmetry
defining the pseudo-palindrome of this attachment site.
The failure to detect recombinase activity mediated by
the φ370, FC1, TG1, RV, FC1, φK38, MR11, A118 and
BL3 integrases in HT1080 cells using deletion substrates
integrated into the vertebrate genome posed the question
as to whether these integrases were active in HT1080 cells
or whether they were simply prevented from acting by the
fact that the target sites were integrated into the genome.
We therefore carried out a series of transient tranfection
experiments in which the deletion substrate plasmid was
transiently transfected into HT1080 cells that had been
stably transfected with an expression plasmid for one of
these integrases or, in the case of the φ370 and TG1
integrases,(where such stably transfected cell lines did not
exist) co-transfected the respective expression plasmid
and deletion substrate plasmid and then analyzed the
extracted DNA for deleted plasmid after 72 hours by PCR.
The recombinants were assayed using one of two PCR re-
actions for which the Bxb 1 or Wβ integrases acted as
positive controls. The results (Figure 4C) demonstrate that
the RV, φK38, MR11, A118 and BL3 integrases were in
fact active in the HT1080 cells and thus we conclude that
these integrases are unable to promote site-specific re-
combination when their substrates are integrated into the
genome of the HT1080 cells but can do so when they are
present extra-chromosomally. We can make no statement
about the φ370, FC1, TG1 integrases as we have no evidence
to determine whether they are expressed.
Comparative integration activities of seven unidirectional
phage integrases in mammalian cells assayed by
recombinase mediated cassette exchange
Site-specific integration, and in particular the exchange
of marker cassettes, collectively termed recombinase me-
diated cassette exchange, is an important technique for
the precise introduction of DNA into cells, in particular
for the comparative analysis of different genes integrated
at the same docking site. The uni-directional serine
integrases are ideally suited to this application as they
require only simple attachment sites and no host accessory
proteins. We wanted to determine which of the seven
integrases that we had identified above as being active in
promoting site-specific deletion in human cells, also func-
tioned in promoting site-specific cassette exchange. Our
previous experiments had shown the merits of using celllines that contained arrays of attachment sites that were
then stably transfected with different integrase-expressing
plasmids as reagents for accurate comparisons of integrase
activity. We first introduced an integration target; attP
array CCAG HyTK attP array expressing the hygromycin-
thymidine kinase fusion flanked by arrays of attP sites into
human HT1080 cells by electroporation and, as before, se-
lected structurally intact, single copy integrants. We then
transfected these cells with individual integrase expression
plasmids for each of the seven integrases that had been
shown to be active in the deletion assay and again selected
for stable integrants. In order to compare the cassette ex-
change activities of the different integrases we then transi-
ently transfected two completely independent clones with
the integration substrate, attB array CCAG Neo attB array
(Figure 2). The work described above indicated that the
integrases were toxic to varying degrees (Additional file 1:
Table S4) and so we expected that there would be different
numbers of resistant clones derived from the transfection
experiments of clones expressing different integrases, des-
pite similar amounts of plasmid being used in the transfec-
tion. We controlled for such differences by transfecting the
integrase-expressing clones with a linearized CCAG Neo
plasmid in a parallel experiment carried out at the same
time as they were transfected with the circular attB array
CCAG Neo attB array plasmid. We selected for G418 re-
sistance in both cases and normalized the experimental
transfections using the yield of clones generated following
transfection with the linearized CCAG Neo. We then
assayed for cassette exchange in the experimental clones
by selecting the G418 resistant clones for gancyclovir re-
sistance to identify those clones that had lost the CCAG
HyTK marker and by PCR in order to identify the attL and
attR products of a site-specific recombination reaction. We
carried out three such assays on two independent attP
CCAG HyTK attP, integrase-expressing clones. The results
(Additional file 1: Table S6, Figure 5A) of these experi-
ments revealed consistent and significant differences be-
tween the seven integrases in terms of their abilities to
mediate site-specific integration. At one extreme were the
Bxb1 and φC31 integrases which promoted efficient
and accurate site specific integration and at the other
were the three integrases Wβ, SPBc and TP901-1
which generated clones that had the phenotypes
expected of cassette exchange through site-specific re-
combination i.e. they were gancyclocvir -resistant and
G418-resistant, but for which we could not obtain PCR
products for attL or attR. We sequenced the attL and
attR sites generated by site-specific integration in the
Bxb1, φC31, R4 and φBT1 integrase-expressing clones.
The Bxb1 and φC31 integrases products were as predicted
but in three cases the attR product generated by the R4
integrase was damaged and similarly one of the three attR
sites generated by the φBT1 integrase was also damaged.
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Figure 5 Comparing the activity of seven different serine recombinases in human HT1080 cells for their utility in recombinase
mediated cassette exchange. A. Cell lines containing a single integrated attP array CCAG HyTK attP array reporter construct and stably
expressing the indicated integrase were transfected with the attB array CCAG neo attB array integration reporter construct using lipofectamine.
The experiment was carried out three times using two independent cell lines for each of the seven integrases. The number of G418-resistant
clones generated by the cassette exchange reaction promoted by the different integrases was normalized by transfection using lipofectamine
with a uniform amount of linearized CCAG neo plasmid. Open bars correspond to the number of colonies generated with the reporter plasmid
divided by the number of colonies generated with the linearized CCAG neo (for the raw data see Additional file 1: Table S6). Between seven and
ten colonies of each transfection were picked and assayed for site-specific recombination by PCR and the total yield of colonies generated by
site-specific recombination is represented by the filled bars. B. Cell lines that had been stably transfected with the indicated integrase expression
construct were transiently transfected with the indicated integration reporter construct and after three days assayed for site specific
recombination by PCR. Two different reactions were used for the assay; one for the Bxb1 integrase and the other for the remaining integrases.
The gel on the final panel shows the PCR reaction products obtained when the indicated reporter constructs were transfected into HT1080 cells
that expressed no integrase and assayed for site-specific recombination by either of the two reactions.
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could be interpreted to suggest that there is a high back-
ground of non-specific integration of the circular plas-
mids into the genome of the HT1080 cells in the absence
of any integrase. Such an interpretation would only be
valid however if it the cells containing the empty expres-
sion vector were transfected with equal efficiency to
those expressing any of the integrases. Given the toxicity
of the integrases seen in the results shown in Additional
file 1: Table S4 this is almost certainly not the case and
thus the relatively apparently high background of non-
specific integration simply reflects the fact that the cells that
do not express integrase are just more easily transfected
than those that do.We wanted to understand how the gancyclocvir-resistant,
G418-resistant, attL-, attR- clones had been generated by
the Wβ, SPBC and TP901-1 integrases. First of all we
wanted to confirm that indeed these integrases were active
in the human cells and in order to investigate this we
assayed extra-chromosomal site-specific recombination
following transient transfection. We therefore took one of
the clones expressing each of these integrases and Bxb1
integrase as a control and then transiently transfected the
cells with the integration substrate plasmids either alone
or together and then confirmed site-specific recombin-
ation by PCR for each of the respective attR and attL sites
(Figure 5B). We supposed that the gancyclocvir-resistant,
G418-resistant, attL-, attR- clones generated by these
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as a result of abortive recombination. We therefore
characterized the structure of the remains of the docking
site (the attP array CCAG HyTK attP array plasmid) and
the integrated attB array CCAGNeo attB array plasmid in
10 clones derived by transfection of either the Wβ or
TP901-1 integrase expressing clones (Figure 6A). This ana-
lysis showed evidence of target site damage with extensive
deletion of the HyTK coding region and flanking sequences.
In the case of the TP901-1 integrase six of the clones (num-
bers 3, 5, 7, 8, 9 and 10) the internal sequences (2, 3 and 4
in Figure 6A) were deleted but flanking sequences (1 and 5
in Figure 6A) were intact suggesting the possibility that the
two attP sites had simply ligated together after deletion of
the intervening DNA. We therefore analysed the residualB
A
attP array PCR
Clone 1 2 3 4
1049(W   ) + + + +
1049+BNB/1 + - - -
1049+BNB/2 + - - -
1049+BNB/3 + - - -
1049+BNB/4 + - - -
1049+BNB/5 + - - -
1049+BNB/6 + - - -
1049+BNB/7 + - - -
1049+BNB/8 + - - -
1049+BNB/9 + - - -
1049+BNB/10 + - - -
1051(TP901) + + + +
1051+BNB/1 + + - -
1051+BNB/2 - - - -
1051+BNB/3 + - - -
1051+BNB/4 - - - -
1051+BNB/5 + - - -
1051+BNB/6 - - - -
1051+BNB/7 + + - -
1051+BNB/8 + - - -
1051+BNB/9 + - - -
1051+BNB/10 + - - -
Figure 6 Analysis of G418-resistant, gancyclovir-resistant, attR-, attL- c
resistant, gancyclovir-resistant, attR-, attL- clones generated by one or other
sequences in each of the two reporter plasmids used in the transfection. T
assayed in the table. Primer sequences used for these assays are listed in th
in the three indicated clones. The diagram shows the regions deleted in thattP sequences in three clones: two, numbers 4 and 9,
showed evidence of deletion of the residual attP sequences
(Figure 6B) while in a third, number 8, the residual attP se-
quence was intact. For both integrases the incoming attB
array CCAG Neo attB array plasmid also showed evidence
of DNA damage, but in this case the damage was associated
with the DNA flanking the cognate attachment sites. Thus
in eight out of ten of the Wβ derived clones one or other of
the attachment sites showed evidence of damage and three
out of the ten TP901-1 derived clones showed evidence of
damage to one or other of the attachment sites. The con-
clusion that we draw from these studies is that DNA dam-
age is limiting the ability of the Wβ, SPBc and TP901-1
integrases to mediate site-specific recombination and cas-
sette exchange in vertebrate cells and compromises theattB array PCR
5 A B C D
+ - - - -
- + + + +
- - - + -
- + + + -
+ + + - -
- + + + -
- + + - -
- + + + +
- - - - -
- + - + -
- + - + -
+ - - - -
+ + + + +
- + + + +
+ - - + -
+ + + + +
+ - - + +
+ + + + -
+ - - + +
+ + + + +
+ + + + +
+ + + + +
lones generated by the Wβ and TP901 integrases. A. Ten G418-
of these two integrases were analysed by PCR across the indicated
he numbers below the plasmid maps indicate the PCR reactions
e (Additional file 1: Table S7). B. Sequence analysis of damaged sites
e remnant of the flanking arrays found in each of three clones.
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we are able to rank the utility of the other four en-
zymes: Bxb1 > φC31 > R4 > φBT1.
As before we also tried to assay the ability of these seven
enzymes to mediate site-specific integration in mouse cells
using transient expression of the integrase. None were de-
tectably active suggesting that as in human cells detectable
integration with this configuration of attachment sites re-
quires stable expression of the integrase.
Conclusions
The major conclusion following from this work is that
although all of the fifteen unidirectional serine integrases
for which both attachment sites have been identified are
active in E.coli, only four of these; Bxb1, φC31, R4 and
φBT1 are able to mediate accurate site-specific integra-
tion into genomic DNA in human cells and rank such
that Bxb1 is marginally better than φC31 and both are bet-
ter than R4 and φBT1 integrases. The three integrases
from the phages Wβ, SPBc, TP901-1 are active in verte-
brate cells as judged by their ability to mediate site-
specific deletion and by their ability to mediate integration
reactions extra-chromosomally but fail to complete suc-
cessful site-specific integration when attempting an inte-
gration by cassette exchange because they damage one orattP array attP array
CCAG 
promoter HyTK
attB arrayattB array CCAG 
promoter
Neo
A
B ge
In
pB
plasmid vector
Figure 7 Hypothetical mechanism for the origin of the G418r gancycl
integration reactions. The figure shows a two step model for the origin o
experiments. A illustrates the first step in the model; the deletion of the Hy
CCAGneo gene. Further details are discussed in the text.other of the participating DNA molecules. Although there
are differences (Figure 4) between the activities seen with
the different integrases in human and mouse cells the data
the overall pattern of activites in the two cell types is such
that it would seem prudent to adopt the B×b 1 integrase
as the first choice in both. We have not investigated the
causes of the different activities but they must reflect in-
teractions between the respective integrases and host
encoded proteins.
Our observations have three practical implications and
pose one question. The practical implications are first
that the B×b 1 integrase should be the first choice for
any genome engineering in vertebrate cells that requires
the use of a serine integrase. Second, that screening for
more serine integrases that can be used in vertebrate
cells is likely to have a low success rate and, third, that it
is necessary that all site-specific integrants, particularly
those generated by the R4 and φBT1 integrases should be
checked for the fidelity of the recombination reaction.
The results obtained in the integration experiments with
the Wβ, SPBc, TP901-1 integrases pose the question of
how such damage arises. One possible mechanism is set
out in Figure 7. In this schema one or other of the attach-
ment sites on the incoming donor plasmid, attB array
CCAG neo attB array forms a synaptic complex with anpBS attP array CCAG HyTK attP array
pBS attB array CCAG neo attB array
cleavage of attachment sites
nome background
deletion of HyTK gene and 
resection of attB array
tegration into genome of damaged Neo plasmid
S attB array CCAG neo attB array with double strand break
ovirr, attR-, attL- clones generated by the serine integrases during
f the GANCr Neor attL- attR-clones arising during the integration
TK gene and B illustrates the second step; the integration of the
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CCAG HyTK attP. The attP and attB sites are then
cleaved but because the two participating sites are embed-
ded in chromatin, strand exchange and/or re-joining of
the DNA backbone are inhibited. Possibly the intermedi-
ate complex, containing the covalent attached integrase
subunits to the cleaved DNA, is unstable and dissociates,
or the process of strand exchange by subunit rotation
is interrupted. The cleaved DNA covalently linked to
integrase subunits leads to resection of the target attP
site by DNA repair pathways which in turn leads to
loss of the counter-selectable HyTK gene (Figure 7A).
The concomitant double strand break in the attB array
CCAG neo attB array plasmid enables this plasmid to inte-
grate efficiently elsewhere in the genome (Figure 7B). How-
ever not all of the gancyclovir-resistant, G418-resistant,
attL-, attR- clones recovered following transfection of the
Wβ or TP901-1 integrase expressing lines showed evidence
of damage at one or other of the donor attB sites and one
assumes that these clones arise by a similar but more com-
plicated mechanism in which the transfected cell takes up
more than one of the these plasmids and that it is one of
the plasmids that have not participated in the abortive at-
tempt at site specific integration that integrates into the
host cell genome.
If chromatin is inhibiting strand exchange by the serine
integrases, one might also have reasonably expected chro-
matin to alter other activities of integrase such as site-
selection. In vitro φC31 integrase only recombines attP ×
attB and is never active on other pairs of attachment sites
including attP with attP or attB with attB. This site-
selectivity is explained as only integrase dimers bound to
attP and to attB can tetramerise to form the synaptic
complex. Within this complex activation of DNA cleavage
occurs. In all of our experiments we did not observed al-
tered site-selectivity or DNA damage arising from some
attempt at recombination of two attP sites or two attB
sites. The absence of any change in site-selectivity in
eukaryotic chromatin implies that the proposed con-
formational differences between integrase bound to an
attP site and to an attB site are robust to withstand
any fortuitous protein-protein interactions arising with
chromatin.
The differences seen between the activities of the
integrases in E. coli and in vertebrate cells on extra-
chromosomal substrates on one hand and on substrates
integrated into the genome on the other and the explan-
ation for the site damage seen in the integration reactions
both suggest that chromatin and other DNA binding pro-
teins are important factors in limiting the activity of site-
specific recombinases in vertebrate cells. It may therefore
be of value in future experiments to determine how the
activity of the integrases vary according to the pos-
ition of the target sites in the genome.Methods
Bacterial strains, plasmids and molecular biology
E. coli K12 DH5α was used as a general cloning host
and propagated on LB medium containing appropriate
supplements or antibiotics (ampicillin (100 μg/ml),
chloramphenicol (50 μg/ml), X-gal (120 μg/ml), IPTG
(40 μg/ml). E. coli BL21 (DE3) was used as a protein
over-expression host. To construct the integrase ex-
pression plasmids, the integrase genes were amplified
by PCR from either phage templates or from plasmids
and inserted into pET21a vector (Novagen) using ei-
ther the In-Fusion cloning system (Clontech) or T4
ligase and compatible restriction sites. The native se-
quences were used as the templates for the amplifica-
tion of all integrase genes except for φC31, A118, FC1
and φK38 for which templates were derived from synthetic,
codon optimised forms (Genescript). Each integrase gene
was modified to include a StrepII tag at the 5′ end and a
nuclear localisation sequence (NLS) at the 3′ end. Reporter
plasmids containing cognate attP and attB sites for all the
integrases were cloned into pACYC184. PCR was used to
amplify the lacZα gene using forward and reverse primers
that contained the attB and attP sites (both approximately
50 bp in length) in head-to-tail orientation (Additional
file 1: Table S1). All of the constructed plasmids were
verified by sequencing (Dundee Sequencing Service).
The sequences of all PCR plasmids and primers used
in the bacterial work are listed in Additional file 1:
Table S1 and Additional file 1: Table S2.
Recombination assays in E. coli
The activities of the cloned integrases in E. coli were
assessed by two assays, which relied on different expres-
sion regimes for the integrases. The expression vector
pET21a has a T7 RNA polymerase promoter to drive the
transcription of the integrase genes and this was used to
ensure expression of the integrase genes in the E. coli
host BL21(DE3). In the absence of T7 RNA polymerase,
as is the case in E. coli DH5a, expression of integrase is
dependent on the recognition of the T7 promoter by
host RNA pol ymerase, which will result in lower
expression.
DH5α cells containing the attB/attP reporter plasmids
were transformed with the appropriate integrase expres-
sion plasmid and plated out on LB agar plates containing
ampicillin (100 μg/ml), chloramphenicol (50 μg/ml), X-gal
(120 μg/ml), IPTG (40 μg/ml) and incubated overnight at
37°C. Recombination between the att sites deletes the
lacZα gene from the reporter plasmid leading to white
colonies and therefore recombinants (white colonies) were
scored amongst a background of non-recombinants (blue
colonies). The transformation plates derived from several
integrases gave rise to only blue or light blue colonies.
Restreaking of these colonies was performed to determine
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mids) could segregate.
BL21(DE3) cells containing the attB/attP reporter plas-
mids were transformed with the appropriate integrase
expression plasmid and plated out on LB agar plates
containing ampicillin and chloramphenicol. After an
overnight incubation a single colony was picked and
grown in 5 ml 2YT containing ampicillin and chloram-
phenicol for 5 h at 37°C. The cells were induced with
IPTG and grown overnight at 20°C after which 1 ml of
this culture was used to prepare plasmid and the pellet
from 4 ml was used in Western blotting to estimate
the expression of integrase. Plasmids extracted from
the overnight culture were used to transform DH5α
cells and colonies growing on plates containing chlor-
amphenicol, X-gal and IPTG after overnight at 37°C
were examined. The proportion of recombinant versus
non-recombinant plasmids was scored from the pro-
portion of white versus blue transformants. PCR was
carried out on 5 individual colonies for each integrase
used in the assay to amplify and sequence the attL
sites, remaining in the recombinant plasmids. Cell pel-
lets from the overnight cultures were resuspended in
LB, incubated in SDS sample buffer and the proteins
separated on a 4-12% SDS gel (Expedeon, UK). The
integrase protein was detected by Western blotting
using a monoclonal antibody against the StrepII tag
conjugated to horseradish peroxidise (IBA, Germany).
The amount of protein present was determined by
comparing the intensities of the bands from the Western
blotting to those from a dilution series of purified
StrepII-tagged φC31 integrase. The intensity of the
bands was determined using ImageJ (NIH) and the
results were expressed as μg of total protein per ml
culture.
In vitro recombination assay
Integrase recombination activity was assayed in vitro
using substrates in which the attachment sites were
present either isolated from other attachment sites or
within the arrays containing the attachment sites for all
15 integrases of interest. The combination of substrates
was as follows: pRT702 (φC31 attP site) and pRT600
(φC31 attB site), pRT702 and pUC57_attB array,
pUC57_attP array and pRT600, pUC57_attP array
and pCCAG_attB array, pCCAG_attP array and pUC57_attB
array. The substrates were incubated in recombination buffer
(10 mM Tris pH 7.5, 100 mM NaCl, 5 mM DTT, 5 mM
spermidine, 4.5% glycerol, 0.5 mg/ml BSA) and φC31
integrase (0 – 700 nM) for 1 h at 30°C [26] After heat in-
activation at 80°C for 10 min the reaction was digested
with HindIII or BamHI and the recombination molecules
detected by gel electrophoresis. Gel images were analysed
using ImageJ (NIH); the intensity of the bands wasdetermined (after subtraction of base line intensities) and
used to quantify the depletion of substrates and appear-
ance of products.
Human cell culture
Human HT1080 fibrosarcoma cells were grown as de-
scribed previously except that RPMI 1640 rather than
Dulbecco’s modified Eagles Medium was used as the un-
supplemented medium. G418, Hygromycin and gancyclovir
(Invitrogen) were used at 400 mg/ml, 100 mg/ml and 20
μM respectively for selection. Cells were transfected with
DNA either by electroporation using a BTX ECM 630 at
400 V, 50 Ω and 250 μF or using Lipofectamine (Invitrogen)
as recommended by the manufacturers. We used electro-
poration with 500 μg of linearized DNA and zeocin selec-
tion for the stable introduction of the integrase expression
constructs and lipofection of 1.6 μg of closed circular DNA
for the transient introduction of either substrate or integrase
expression construct.
ES cell manipulation and analysis
Targeting vector construction and gene targeting
The insertion of the attP-Hygro-TK-attP array at the
ROSA26 locus was performed by gene targeting in
E14tg2a ES cells (Additional file 1: Figure S1). A targeting
vector for the ROSA26 locus, pRosa26.10 [27] was adapted
by the insertion of an AscI-NsiI-SacII polylinker, made by
oligonucleotide annealing, into the AscI and SacII sites 3′
and 5′ of the homology arms, creating plasmid pRosa26-
PL. The final targeting vector, pRosa26-PHB containing
the attP-Hygro-TK-attB arrays, was constructed by
inserting the arrays from pBSattPCCAGHyTKattB into
pROSA26-PL via the 5′ AscI and the 3′ NsiI sites.
The targeting vector was linearized by XhoI digestion
and electroporated into 1×107 E14tg2a cells at 500 V,
3 uF. Cells were plated on gelatin and recombinant
clones were recovered by selection in Hygromycin 75 ug/ml.
Targeted clones were identified by long range PCR screening
using primers 5′-GGCACTACTGTGTTGGCGGA-3′
and 5′-GGCCAGCTTATCGATACCGT-3′ for the 5′ end;
5′-AGCGAGGGCTCAGTTGGGCTGTTT-3′ and 5′-CTC
AGTGGCTCAACAACACTTGGTCA-3′ for the 3′ end.
Single copy integration events were confirmed by Southern
blotting using an EcoRV digest and an internal Hygromycin
probe.
Transient assays of integrase-mediated deletion in ES cells
1 × 106 attP-Hygro-TK-attB ES cells were electroporated
with 5 μg of the integrase vectors and 200 ng of a con-
trol plasmid containing a functional neomycin cassette
to control for transfection efficiency. Electroporation was
performed using the Neon transfection system (Invitrogen)
(3 × 1400 V, 10 ms). Cells were plated on 2 wells of a 6 well
plate and selected in either 3 μM Gancyclovir or 350 μg/ul
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stained in methylene blue and counted. Deletion efficien-
cies were calculated from the number of gancycolvir resist-
ant colonies normalised against transfection efficiency by
assessing the number of G418 resistant clones in the rep-
lica plating. All comparison transfection experiments were
repeated twice using 2 independently targeted ES cell
clones.
Individual gancyclovir resistant colonies were picked and
expanded for the preparation of genomic DNA. PCR
analysis using primers del-Rosa-F1 (5′ GATCGAGGTGCC
CCAACTGGGGTAACCT TT-3′) and del-Rosa-R1 (5′-C
CGCGGATGCATAGCGGATAACAATTTCAC-3′) which
bind at the very 5′ and 3′ of the integrated attP-Hygro-TK-
attB array and amplify across the expected deletion events
(Additional file 1: Figure S1), was performed to confirm the
deletion event had occurred. PCR products were sequences
to assess the nature and position of the attP x attB recom-
bination and the sequences of the resulting attR sites.
Gancyclovir resistant clones that failed to yield an amplicon
using this PCR strategy were further investigated for aber-
rant recombination events using primers which amplify the
hygromycin sequence (5′- GAAGAATCTCGTGCTTTCA
GCTTCGATG-3′; 5′- AATGACCGCTGTTATGCGGCC
ATTG-3′) and the thymidine kinase sequence (5′-TCTG
GACCGATGGCTG TGTA-3′; 5′-AGACGTGCATGGA
ACGGAGG-3′).
Additional file
Additional file 1: Table S1. Plasmids used to assay integrase activity in
E.coli, Table S2. Primers used to construct expression plasmids and assay
integrase activity in E.coli, Table S3. The results of two transient
transfection experiments in which the integrase shown in the first
column was introduced into each of two cell lines containing a single
copy of the deletion assay reporter plasmid located intact at a single site
in the genome of HT1080 cells. Table S3. Assaying integrase activity in
human HT1080 cells by deletion activity following transient transfection
of integrase expression plasmid, Table S4. Assaying integrase activity in
human HT1080 cells by deletion activity following genomic integration of
integrase expression plasmid, Table S5. Assaying integrase activity in
mouse ES cells by deletion activity following transient transfection of
integrase expression plasmid, Table S6. Assaying site-specific integration
activity of seven integrases able in human HT1080 cells, Table S7.
Primers used to analyse re-arrangements associated with cassette
exchange integrations: illustrated in Figure 6 of main text, Figure S1. (A)
Targeting the ROSA26 locus in mouse ES cells with a deletion reporter
construct. (B) the targeted locus before deletion (C) the targeted locus
after deletion. Sequences of the Del-Rosa primers are in the main text,
Figure S2. western blot analysis of φC31 and φBT1 integrase expression
in HT1080 clones that contain a single integrated copy of the attP array
CCAG HyTk attB array reporter and have been stably transfected with an
integrase expression plasmid but fail to delete the HyTk gene.
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